Monomers Sales Manager NAFTA jobs in United States
cer-icon
Apply on Employer Site
company-logo

Cathay Biotech Inc. · 5 hours ago

Monomers Sales Manager NAFTA

Cathay Biotech Inc. is a leading company in the bio-based monomers sector, looking for a motivated Monomers Sales Manager for the NAFTA market. The role involves driving sales, managing customer relationships, and providing market intelligence to achieve profitability and growth.

BiotechnologyIndustrialManufacturingPharmaceutical

Responsibilities

Set and monitor sales targets and KPIs for the NAFTA region
Develop and maintain relationships with key customers and partners
Manage leads and offers for clients including specification, technical and pricing
Identify and pursue new business opportunities and markets
Analyze market trends and customer feedback
Collaborate with marketing, product, and support teams to ensure customer satisfaction and retention

Qualification

Sales managementChemistry knowledgeMarket analysisCustomer relationship managementNegotiation skillsFluent in EnglishFluent in ChinesePresentation skills

Required

Bsc degree or above
Proven track record of achieving sales goals and growing revenue
Experience working with chemistry leading customers
At least 10 years' of experience in sales management in the chemical industry, preferably in the NAFTA market
Experience working with a wide variety of customers, in a home office/field-base capacity
Strong market analytical skills, communication and negotiation skills
Fluent in English
Excellent communication, negotiation, and presentation skills
Willingness to travel frequently within NAFTA

Preferred

Prefer in monomer Science or Chemistry and relative majors
Chinese would be a plus

Company

Cathay Biotech Inc.

twittertwitter
company-logo
Cathay Biotech Inc. is a listed company on the Shanghai stock exchange’s STAR market (symbol: 688065.SH).

Funding

Current Stage
Public Company
Total Funding
$921.87M
Key Investors
China Merchants GroupHBM Healthcare Investments
2023-06-26Post Ipo Equity· $911.9M
2020-08-12IPO
2019-06-14Series B· $9.96M
Company data provided by crunchbase